News Focus
News Focus
Followers 10
Posts 577
Boards Moderated 0
Alias Born 12/18/2010

Re: Hoskuld post# 485227

Saturday, 03/22/2025 9:58:13 PM

Saturday, March 22, 2025 9:58:13 PM

Post# of 517434
Hoskuld, I also would have preferred that the Rett trial was successful and approved to help with this disease. I had invested with this as my expected outcome, so both financial and in support of Anavex providing help for those cursed with Rett. There was enough positive results with the trial, as small as it was, that it did lead me to feel that A 2-73 was of benefit. This, combined with what was known at the time for A 2-73 for Alzheimer's and with my experience with rapamycin, was enough for me to continue investing as the stock price dropped. Not that I was completely comfortable...but confident enough with what I understood on the science to make the investment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News